Department of Obstetrics and Gynecology, Spedali Civili of Brescia, Piazzale Spedali Civili 1, Brescia, 25126, Italy.
Department of Obstetrics and Gynecology, University of Brescia, Italy.
Eur J Surg Oncol. 2019 Nov;45(11):2115-2119. doi: 10.1016/j.ejso.2019.07.029. Epub 2019 Jul 29.
to assess the prognostic role in recurrence and survival of perineural invasion (PNI) in vulvar squamous cell cancer (VSCC).
Patients underwent primary surgery for VSCC from January 2009 to December 2016 served as the study cohort. We collected demographic, clinical, pathological characteristics and follow-up data, and we compared them among PNI-negative versus -positivepatients. We calculated disease-free survival (DFS) and overall survival (OS) using Kaplan-Meier and univariate log-rank test. We conducted a multivariate analysis with cox-proportional hazard models for DFS and OS, including age, tumor size, depth of invasion, free tumor margin <8 mm, high-grade histology, lymph vascular space invasion, PNI, extracapsular lymph nodal disease, lymph nodal ratio >0.2 and FIGO Stage 2009 (Early I-II versus Advanced III-IV).
We found 74 patients with a PNI prevalence of 31.1%. The 5-year DFS was favourable for PNI-negative patients (72% versus 18%; p = 0.00). The 5-year OS was 75% versus 35% in favor of PNI-negative patients (p = 0.00). The subgroup analysis conducted among stage confirmed a decreased DFS and OS in PNI-positive patients. Multivariate analysis showed that PNI (HR 2.74; CI95% 1.10-7.13; p = 0.03) and extracapsular lymph nodal disease (HR 13.54; CI95% 2.87-64.07; p = 0.01) are independent prognostic factors for earlier recurrence. OS was significantly reduced in case of PNI (HR 4.93; CI95% 1.33-18.35; p = 0.01) and extracapsular lymph nodal disease (HR 10.63; CI95% 1.65-68.57; p = 0.01).
PNI is an independent prognostic factor for aggressive behavior and unfavorable course in VSCC and should be considered in adjuvant treatment planning.
评估外阴鳞状细胞癌(VSCC)中神经周围侵犯(PNI)与复发和生存的相关性。
本研究纳入了 2009 年 1 月至 2016 年 12 月期间行原发性手术治疗的 VSCC 患者作为研究队列。我们收集了患者的人口统计学、临床和病理特征及随访数据,并对 PNI 阴性和阳性患者进行了比较。我们使用 Kaplan-Meier 法和单因素对数秩检验计算无病生存率(DFS)和总生存率(OS)。我们通过 COX 比例风险模型进行多变量分析,包括年龄、肿瘤大小、浸润深度、游离肿瘤边缘<8mm、高级别组织学、脉管间隙侵犯、PNI、囊外淋巴结转移、淋巴结比值>0.2 和 FIGO 2009 分期(早期 I-II 期与晚期 III-IV 期)。
我们发现 74 例患者存在 PNI,占比 31.1%。PNI 阴性患者的 5 年 DFS 更好(72%比 18%;p=0.00),OS 也更好(75%比 35%;p=0.00)。在分期亚组分析中,PNI 阳性患者的 DFS 和 OS 降低。多变量分析显示,PNI(HR 2.74;95%CI 1.10-7.13;p=0.03)和囊外淋巴结转移(HR 13.54;95%CI 2.87-64.07;p=0.01)是复发的独立预后因素。PNI(HR 4.93;95%CI 1.33-18.35;p=0.01)和囊外淋巴结转移(HR 10.63;95%CI 1.65-68.57;p=0.01)也是 OS 的独立预后因素。
PNI 是 VSCC 侵袭性行为和不良预后的独立预后因素,应考虑纳入辅助治疗计划。